New combo therapy aims to shrink rectal tumors with fewer side effects
Disease control
Not yet recruiting
This phase 2 trial tests a new approach for locally advanced rectal cancer: using MRI-guided, reduced-field short-course radiotherapy together with immunotherapy and chemotherapy before surgery. The goal is to shrink the tumor effectively while causing fewer side effects than sta…
Phase: PHASE2 • Sponsor: Longhao Li • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC